Skip to main content

Learn More About an FDA Approved Treatment for Metastatic Triple-Negative Breast Cancer

March 23, 2021

Brought to you by Gilead Sciences, Inc.

Gilead Sciences, Inc., is proud to present a virtual meeting on metastatic triple-negative breast cancer hosted by On24 at the ONS Annual 2021 Conference. Our speaker, Tiffany Kessler, APRN, MSN, AGACNP-BC 

Nurse Practitioner, Breast Oncology, Texas Oncology, Baylor Sammons Cancer Center will discuss: 

  • The clinical landscape of metastatic TNBC 
  • Appropriate populations for a metastatic TNBC therapy 
  • Safety and efficacy of a therapy in patients with metastatic TNBC 

Please join us for this virtual presentation on Thursday, April 22, from 2:00-2:45 pm ET 

Gilead Sciences, Inc. is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, with the goal of creating a healthier world for all people. The company is committed to advancing innovative medicines to prevent and treat life-threatening diseases, including HIV, viral hepatitis and cancer. Gilead operates in more than 35 countries worldwide, with headquarters in Foster City, California. For more information on Gilead Sciences, please visit the company’s website at


Blog category